by chuck_ltd | 11 Oct, 2017 | Brexit
On Saturday 4 Oct, the European Commission (EC) published its assessment of the bids by 19 Member States to host the European Medicines Agency (EMA) when it relocates from London in March 2019. As instructed by the Member States, the EC has been careful to avoid...
by chuck_ltd | 6 Jan, 2017 | Biosimilars, CHCUK News & Articles
Europe’s biosimilar market continues to develop, with biosimilars in new classes approved and pending in applications before the European Medicines Agency (EMA). 22 biosimilars are approved in eight different product classes and 16 biosimilar applications, including...
by chuck_ltd | 14 Apr, 2016 | CHCUK News & Articles, News
The European Medicines Agency (EMA) has begun running a series of modular training courses to support stakeholders in using EudraVigilance, the centralized database for managing information on suspected adverse reactions reported with medicines authorised in the...
